The 20 Best Hepatectomy Doctors near Ann Arbor, MI

Christopher Sonnenday, M.D., M.H.S., is the Darrell A. Campbell, Jr, M.D., Collegiate Professor of Transplant Surgery at the University of Michigan and Transplant Center Director for University of Michigan Health. He serves as Executive Vice Chair of the Department of Surgery, Surgical Director of Living Donor Liver Transplantation, and Surgical Director of the Multidisciplinary Liver Tumor Program for Michigan Medicine. He is a Professor in the Department of Surgery, Section of Transplantation, and Professor of Health Management and Policy at the School of Public Health. Dr. Sonnenday received his medical degree from Vanderbilt University in 1997, and completed his General Surgery residency at the Johns Hopkins University in 2005. While a research fellow in transplantation from 2000 to 2003, he completed a Masters of Health Sciences in Clinical Investigation at the Bloomberg School of Public Health. After completion of his residency, Dr. Sonnenday continued at Johns Hopkins as a Fellow in Surgical Oncology and Instructor of Surgery until 2006, and he completed a fellowship in abdominal transplant surgery at the University of Michigan in 2008. His primary academic and research interests include the study of frailty in liver transplant candidates, machine perfusion in liver transplantation, the overlap of transplant and oncology, quality collaboratives in transplantation, and leadership development in academic surgery.Clinical Specialization: Dr. Sonnenday's clinical interests focus on liver transplantation, hepatobiliary and pancreatic surgery, and general surgery procedures in patients with advanced liver disease. He sees patients in the Multidisciplinary Liver Tumor Clinic at the University of Michigan Rogel Cancer Center and the Transplant Clinic at the Taubman Center. Dr. Sonnenday is rated as an Advanced provider by MediFind in Hepatectomy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bile Duct Cysts, Liver Failure, Cholangiocarcinoma (Bile Duct Cancer), Liver Transplant, and Hepatectomy. Dr. Sonnenday is board certified in Surgery.

Seth A. Waits, MD is a faculty member in the Section of Transplant Surgery. Dr. Waits received his medical degree from the University of Toledo in 2009. He completed his general surgery residency and abdominal transplant fellowship at the University of Michigan in 2018. While a research fellow in transplantation and general surgery from 2013-2015, he investigated quality improvement efforts across hospital collaboratives and looked for novel methods of surgical education. He is board certified by the American College of Surgeons and holds a certificate of completion of fellowship from the American Society of Transplant Surgeons. Clinical Specialization:Dr. Waits clinical focus is on liver and kidney transplants, benign and malignant disease of the liver and biliary tree and general surgery in patients with end-stage liver and kidney disease. Dr. Waits is rated as an Advanced provider by MediFind in Hepatectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Liver Failure, End-Stage Renal Disease (ESRD), Cholangiocarcinoma (Bile Duct Cancer), Liver Transplant, and Kidney Transplant. Dr. Waits is board certified in Surgery.

Michael Englesbe, MD, FACS is the Cyrenus G Darling Sr M.D. and Cyrenus G Darling Jr M.D. Professor of Surgery at the University of Michigan in the Section of Transplantation Surgery. Dr. Englesbe received his undergraduate degree at Yale University in New Haven, Connecticut in 1993. He went on to obtain his medical degree in 1997 from the Robert Wood Johnson Medical School and completed his general surgery residency at the University of Michigan Health System in 2004. From 2000 to 2002, Dr. Englesbe did a surgical research post-doctoral fellowship at the University of Washington Medical Center in Seattle, Washington. He does kidney and liver transplantation in adults and children. He has a specific expertise in portal hypertension in children and adults.Education Focus:Dr. Englesbe particularly enjoys working with undergraduate students, medical students, and young physician trainees. He serves as the Department of Surgery Vice Chair for Resident Mentorship and the University of Michigan Medical School Capstone Curriculum Director.Clinical Specialization:Dr. Englesbe specializes in kidney and liver transplantation in adults and children. He has a specific expertise in portal hypertension in children and adults. Dr. Englesbe is rated as an Advanced provider by MediFind in Hepatectomy. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Hernia, Liver Failure, End-Stage Renal Disease (ESRD), Liver Transplant, and Kidney Transplant. Dr. Englesbe is board certified in Surgery.

Dr. Clifford S. Cho is the C. Gardner Child Professor of Surgery in the Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery at Michigan Medicine.Dr. Cho is an Honors graduate of Brown University and AOA graduate of the Vanderbilt University School of Medicine. He completed his general surgery residency and transplantation immunology postdoctoral research fellowship at the University of Wisconsin, where he served as Chief Administrative Resident. He completed his surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center, where he served as Chief Administrative Fellow. He joined the faculty of the University of Wisconsin School of Medicine and Public Health in 2006, where he was promoted to Associate Professor with Tenure and named the Ronald and Patricia Kissinger Professor of Surgical Oncology. He served as Chief of the Division of Surgical Oncology, Associate Residency Program Director, and co-Director of the Gastrointestinal Disease Oriented Team in the University of Wisconsin Carbone Cancer Center before moving to the University of Michigan in 2016.Dr. Cho’s academic focus is on hepatopancreatobiliary and gastrointestinal malignancies, cancer immunology, and the mentorship of clinical and research trainees. He has lectured on these academic interests in over 15 national and international visiting professorships, and was named the James IV Traveler in 2014. He has published over 120 peer-reviewed manuscripts and book chapters and currently serves on the editorial boards of Surgery and the Journal of Gastrointestinal Surgery. He is the Principal Investigator of a VA Merit Review-funded cancer immunology laboratory that is working to understand cancer-induced T cell suppression, and to identify novel T cell-based strategies for cancer immunotherapy. His laboratory has been continuously funded since 2006 by extramural support from the Veteran’s Administration, National Institutes of Health, American College of Surgeons, and Central Surgical Association, and is a member of the VA Oncology Merit Review study section. He has held a number of national academic leadership positions and is a member of over 15 surgical societies, including the American Surgical Association, Society of Clinical Surgery, Society of University Surgeons, and Surgical Biology Club II. Dr. Cho is rated as an Advanced provider by MediFind in Hepatectomy. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Cho is board certified in Surgery.

Evan Glazer, MD, PhD, FACS, is the Clinical Director of the Pancreatic Cancer Program at Michigan Medicine and the Associate Director of Clinical Research in the Rogel and Blondy Center for Pancreatic Cancer. Dr. Glazer earned his medical degree and a master's degree in public health at the George Washington University in Washington, DC. Subsequently, he completed residency in general surgery and completed a PhD in Cancer Biology at the University of Arizona, in Tucson, AZ. Dr. Glazer completed an NIH funded T32 training fellowship at the M.D. Anderson Cancer Center in Houston, TX. He completed a fellowship in complex general surgical oncology at the H. Lee Moffitt Cancer Center in Tampa, FL. Dr. Glazer is board certified in complex general surgical oncology and general surgery. His clinical and research focuses are on pancreatic and liver malignancies.After completing fellowship in Tampa, Dr. Glazer joined the University of Tennessee Health Science Center in Memphis, TN, and rose in rank to Associate Professor. He served as program director of the complex general surgical oncology fellowship there as well as associate program director for research in the general surgery residency program. Dr. Glazer is a member of the American College of Surgeons, American Association for Cancer Research, Society of Surgical Oncology, Association of Academic Surgery, and American Society of Clinical Oncology. With a national reputation, he has served on the Hepatobiliary Panel and Pancreatic Adenocarcinoma Panel for the National Comprehensive Cancer Network. He has served numerous roles for the Society of Surgical Oncology. Dr. Glazer is rated as an Advanced provider by MediFind in Hepatectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Glazer is board certified in Surgery and Complex General Surgical Oncology.

Dr. Hari Nathan is a board-certified complex general surgical oncologist and Associate Professor of Surgery with Tenure. Dr. Nathan completed both his undergraduate and medical education with honors at The Johns Hopkins University. He also completed advanced training in health services research and was awarded a PhD from The Johns Hopkins Bloomberg School of Public Health. Dr. Nathan completed his clinical residency training in general surgery at The Johns Hopkins Hospital. He subsequently completed a clinical fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center, where he also served as the Chief Administrative Fellow in Surgery. He joined the faculty of the University of Michigan in 2014. Clinical Specialization: Dr. Nathan's clinical focus includes the multi-disciplinary treatment of tumors of the pancreas, liver, bile duct, and stomach. He has particular interests in the treatment of liver metastases from colorectal cancer and directs Michigan Medicine’s Hepatic Artery Infusion Pump (HAIP) Program. He also serves as the Surgical Director of the Multidisciplinary Pancreatic Cancer Clinic, coordinating the efforts of a multidisciplinary team at the busiest pancreatic cancer program in Michigan. Dr. Nathan is rated as an Advanced provider by MediFind in Hepatectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Nathan is board certified in Surgery and Complex General Surgical Oncology.

John C. Magee, M.D., is the Jeremiah & Claire Turcotte Professor of Transplant Surgery. Dr. Magee received his undergraduate degree from the University of Pennsylvania and his medical degree from Jefferson Medical College. He completed his General Surgery residency at the University of Michigan in 1996. During his residency, Dr. Magee spent three years as a research fellow in the Department of Surgery at Duke University Medical Center where he focused on endothelial cell biology in inflammation and xenotransplantation. He also completed the Post-Doctoral Research Training Program at the University of Michigan. Following general surgery training, he completed a two-year multi-organ transplant surgery fellowship at the University of Michigan. He joined the faculty in 1998.Dr. Magee's clinical interests include the care of adults and children requiring kidney, pancreas and liver transplantation, as well as management of immunosuppressive therapy and its complications. Dr. Magee is currently the head, section of transplantation and director of the pediatric liver and kidney transplant program. Dr. Magee is rated as an Experienced provider by MediFind in Hepatectomy. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Liver Failure, Chronic Antibody-Mediated Rejection, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Magee is board certified in Surgery.

Dr. Meredith Barrett is a clinical lecturer in Transplant Surgery at the University of Michigan. She graduated Magna Cum Laude from Kent State in 2008, and then matriculated through a 6-year premed-medical school program at Northeast Ohio Medical University, graduating in 2012. She completed her residency training in general surgery at the University of Michigan in 2019. Notably during her training, she won the Hilary Sanfey Outstanding Resident Award in 2017, a national award given to one surgery resident annually who demonstrates support of women in surgery and the potential to be a leader in surgery nationally.Dr. Barrett continued her post-residency training at Michigan completing a two-year fellowship in abdominal transplantation where she honed her technical skills in kidney, pancreas, and liver transplantation. Her clinical practice currently includes abdominal transplantation surgery (adult and pediatric), dialysis access surgery and general surgery.In addition to transplantation and surgical education, Dr. Barrett is committed to resident and faculty wellness. She founded the Women in Surgery program at the University of Michigan and encourages mental health awareness and work-life balance. Outside of the operating room, Dr. Barrett enjoys being outdoors, particularly running. She has completed ten marathons and multiple other road races. Dr. Barrett is rated as an Experienced provider by MediFind in Hepatectomy. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses End-Stage Renal Disease (ESRD), Liver Failure, Wandering Spleen, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Barrett is board certified in Surgery.

Danielle Haakinson is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Haakinson is rated as an Experienced provider by MediFind in Hepatectomy. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Chronic Antibody-Mediated Rejection, Liver Failure, Polycystic Kidney Disease, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Haakinson is board certified in Surgery.

Dr. Sheetz is an assistant professor of surgery and a faculty member in the Section of Transplant Surgery. He received his medical degree from the University of Michigan where he also completed his general surgery residency. He went on to complete his transplant surgery fellowship at the University of California San Francisco (UCSF). He is board certified by the American Board of Surgery and is a member of the American College of Surgeons and American Society of Transplant Surgeons.Clinical Specialization: Dr. Sheetz’s clinical interests include liver, kidney, and pancreas transplant. He also performs laparoscopic donor nephrectomy for living donor kidney transplants. He has a special interest in normothermic machine perfusion in liver transplant. Dr. Sheetz is rated as an Experienced provider by MediFind in Hepatectomy. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Liver Failure, End-Stage Renal Disease (ESRD), Umbilical Hernia, Gallbladder Removal, and Liver Transplant. Dr. Sheetz is board certified in Surgery.

Dr. Chaudhary is a physician/surgeon scientist and a practicing Neurointerventionalist for the past 15 years. He is a neurovascular imaging expert as well. His training background is pretty diverse, with medical school in India, graduate and postgraduate training in general surgery and general radiology in United Kingdom followed by fellowships in Neurointerventional Radiology (NIR) and Neuro-Diagnostic Radiology (NDR) in adults and children in London, England, UK and at the University of Michigan in USA. He treats neurovascular and other diseases of the brain and spinal cord including its bony casing plus Head Neck Face and orbit vascular malformations in both adults and children. He has over 180 peer reviewed publications to his name and is a keen translational researcher of Hemorrhagic and Ischemic stroke. He extensively reviews manuscripts for several national and international journals of repute in the fields of Neurointervention and Neuroimaging. Apart from his primary appointment in the department of Radiology, he has dry appointments in the departments of Neurosurgery, Neurology and Otorhinolaryngology. In the spirit of collaborative care for patients, which is at the core of the mission of Michigan Medicine, his team are part of the comprehensive stroke center, spine oncology program and the retinoblastoma treatment program at our institution. Dr. Chaudhary is rated as an Experienced provider by MediFind in Hepatectomy. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Arteriovenous Malformation, Stroke, Brain Aneurysm, Thrombectomy, and Stent Placement.

Dr. Ferguson is a Clinical Assistant Professor of Surgery in the Division of Hepato-pancreato-biliary Surgery. Following undergraduate studies in Molecular & Integrative Physiology at the University of Illinois, he earned an MD and a PhD in Cancer Biology at the University of Chicago. He completed a general surgery residency at the University of Chicago, where he served as an administrative chief resident and completed a medical education fellowship, followed by a clinical fellowship in complex general surgical oncology at Memorial Sloan Kettering Cancer Center. He is board-certified in general surgery and complex general surgical oncology.He has won numerous teaching awards at every stage of his career. He is the co-editor of Difficult Decisions in Surgical Oncology—An Evidence-Based Approach. He is active in the American College of Surgeons, Society of Surgical Oncology, Americas Hepato-Pancreato-Biliary Association, and Association for Surgical Education.Clinical Specialization: Dr. Ferguson's clinical expertise is in the management of cancers and premalignant conditions of the pancreas, liver, bile ducts, gallbladder, and stomach. Dr. Ferguson is rated as an Experienced provider by MediFind in Hepatectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Bile Duct Cysts, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection. Dr. Ferguson is board certified in Surgery and Complex General Surgical Oncology.

Ben E. Biesterveld, M.D. is a faculty member in the Section of Transplant Surgery.Dr. Biesterveld received his medical degree from the Medical College of Wisconsin. He completed his general surgery residency at the University of Michigan and transplant surgery fellowship at the University of Wisconsin. He is board certified by the American Board of Surgery and a member of the American Society of Transplant Surgeons. Dr. Biesterveld is rated as an Experienced provider by MediFind in Hepatectomy. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Traumatic Brain Injury, Liver Failure, Alcoholic Cirrhosis, Kidney Transplant, and Liver Transplant. Dr. Biesterveld is board certified in Surgery.

Dr. Su is the H. Marvin Pollard Collegiate Professor of Gastroenterology, III. In addition to her appointment at the University of Michigan, she is also the Associate Chief of Medicine for Subspecialty Care and Access as well as Chief of the Gastroenterology Section at the VA Ann Arbor Healthcare System. Her research focus is on innovative approaches to specialty care and access. She also serves as the Director of the Morphomics Analysis Group at the University of Michigan where she leads a multidisciplinary collaborative of physicians, biostatisticians and engineers developing methods for analyzing medical imaging. By linking imaging features to clinical outcomes, they are able to use quantitative imaging data to improve the diagnosis and prognosis of patients with liver disease as well as hepatocellular carcinoma (HCC).Dr. Su serves as the President of the American Association for the Study of Liver Diseases (AASLD), the leading organization of scientists and health care professionals committed to preventing and curing liver disease. She is committed to the vision of the organization to prevent and cure liver disease. Dr. Su is rated as an Experienced provider by MediFind in Hepatectomy. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Cirrhosis, Hepatitis C, Crohn's Disease, Liver Transplant, and Small Bowel Resection.

James Knol is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Knol is rated as an Experienced provider by MediFind in Hepatectomy. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Stomach Cancer, Cholangiocarcinoma (Bile Duct Cancer), Hernia Surgery, and Pancreatectomy.